Polymorphism of the Glutamate Transporter Protein EAAT2 and Migraine Transformation into Chronic Daily Headache

키워드

참고문헌 (41)

1. Mathew NT, "Transformation of episodic migraine into daily headache: analysis of factors", Headache, 22, pp.66~68 (1982)
2. Jensen R, "Epidemiology and comorbidity of headache", Lancet Neurol, 7, pp.354~361 (2008)
3. Zwart JA, "Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study", Neurology, 61, pp.160~164 (2003)
4. Lipton RB, "Chronic daily headache: is analgesic overuse a cause or a consequence", Neurology, 61, pp.154~155 (2003)
5. Russell MB, "Familial occurrence of chronic tension-type headache", Cephalalgia, 19, pp.207~210 (1999)
6. Cevoli S, "A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse", Eur J Neurol, 13, pp.1009~1013 (2006)
7. 김중석, "Serotonergic activity contributes to analgesic overuse in chronic tension-type headache", HEADACHE, 45(9), pp.1229~1235, BLACKWELL PUBLISHING
8. Aurora SK, "Spectrum of illness: understanding biological patterns and relationships in chronic migraine", Neurology, 72, pp.8~13 (2009)
9. Hill RG, "An ionophoretic study of the responses of rat caudal trigeminal nucleus neurones to non-noxious mechanical sensory stimuli", J Physiol, 327, pp.65~78 (1982)
10. Xiao Y, "Release of glutamate and CGRP from trigeminal ganglion neurons: role of calcium channels and 5-HT1 receptor signaling", Mol Pain, 4, pp.12~ (2008)
11. Vikelis M, "The role of glutamate and its receptors in migraine", CNS Neurol Disord Drug Targets, 6, pp.251~257 (2007)
12. Oshinsky ML, "Neurochemistry of trigeminal activation in an animal model of migraine", Headache, 46(Suppl 1), pp.39~44 (2006)
13. Vieira DS, "Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine", Headache, 47, pp.842~847 (2007)
14. Peres MF, "Cerebrospinal fluid glutamate levels in chronic migraine", Cephalalgia, 24, pp.735~739 (2004)
15. Danbolt NC, "Glutamate uptake", Prog Neurobiol, 65, pp.1~105 (2001)
16. Lauriat TL, "EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders", Mol Psychiatry, 12, pp.1065~1078 (2007)
17. Arriza JL, "Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex", J Neurosci, 14, pp.5559~5569 (1994)
18. Lizasoain I, "Targets of cytoprotection in acute ischemic stroke: present and future", Cerebrovasc Dis, 21(Suppl 2), pp.1~8 (2006)
19. Meyer T, "Genomic organization of the human excitatory amino acid transporter gene GLT-1", Neuroreport, 8, pp.775~777 (1997)
20. Mallolas J, "A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke", J Exp Med, 203, pp.711~717 (2006)
21. Pampliega O, "Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis", J Neuroimmunol, 195, pp.194~198 (2008)
22. Jackson M, "Polymorphisms in the glutamate transporter gene EAAT2 in European ALS patients", J Neurol, 246, pp.1140~1144 (1999)
23. Sander T, "Variation of the genes encoding the human glutamate EAAT2, serotonin and dopamine transporters and Susceptibility to idiopathic generalized epilepsy", Epilepsy Res, 41, pp.75~81 (2000)
24. Jen JC, "Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures", Neurology, 65, pp.529~534 (2005)
25. "The International Classification of Headache Disorders: 2nd edition", Neurol Neurochir Pol, 40, pp.7~41 (2006)
26. Baranauskas G, "Sensitization of pain pathways in the spinal cord: cellular mechanisms", Prog Neurobiol, 54, pp.349~365 (1998)
27. Urban MO, "Central mechanisms in pain", Med Clin North Am, 83, pp.585~596 (1999)
28. Dodick DW, "Review of comorbidities and risk factors for the development of migraine complications (infarct and chronic migraine)", Cephalalgia, 29(Suppl 3), pp.7~14 (2009)
29. Bigal ME, "Modifiable risk factors for migraine progression", Headache, 46, pp.1334~1343 (2006)
30. Filatova E, "Evidence of persistent central sensitization in chronic headaches: a multi-method study", J Headache Pain, 9, pp.295~300 (2008)
31. Boes CJ, "Pathophysiology and management of transformed migraine and medication overuse headache", Semin Neurol, 26, pp.232~241 (2006)
32. Heinricher MM, "Descending control of nociception: specificity, recruitment and plasticity", Brain Res Rev, 60, pp.214~225 (2009)
33. Lake AE 3rd, "Medication overuse headache: biobehavioral issues and solutions", Headache, 46(Suppl 3), pp.88~97 (2006)
34. Saper JR, "Medication overuse headache (MOH) is a biobehavioural disorder", Cephalalgia, 25, pp.545~546 (2005)
35. Ferrari A, "Similarities and differences between chronic migraine and episodic migraine", Headache, 47, pp.65~72 (2007)
36. Matsumoto Y, "The -181 A", C polymorphism in the excitatory amino acid transporter-2 gene promoter affects the personality trait of reward dependence in healthy subjects, 2007, pp.427, 99~102
37. Lötsch J, "Genetic modulation of the pharmacological treatment of pain", Pharmacol Ther, 124, pp.168~184 (2009)
38. Kosek E, "Genetic variation in the serotonin transporter gene (5-HTTLPR, rs25531) influences the analgesic response to the short acting opioid Remifentanil in humans", Mol Pain, 5, pp.37~ (2009)
39. Oertel B, "mutations that prevent pain: implications for future pain medication", Pharmacogenomics, 9, pp.179~194 (2008)
40. Gentile G, "Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine", J Headache Pain, 11, pp.431~435 (2010)
41. Gentile G, "Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine", J Headache Pain, 11, pp.151~156 (2010)

관련 논문AI추천